NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE197598 Query DataSets for GSE197598
Status Public on Mar 03, 2022
Title Protein kinase inhibitor-mediated immunoprophylactic and immunotherapeutic control of colon cancer
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary An innovative multikinase inhibitor (H89)-based antitumor immunotherapy in colorectal cancer (CRC) is presented. The study was designed to evaluate the effect of H89 on colon tumor growth and carcinogenesis through in vivo analyses. Syngeneic mouse models of CRC cancer in BALB/c mice and chemically colon tumorigenesis, reveals that H89 delays colon oncogenesis, related to a preventive effect, and prevents tumor growth, underlying an antitumor effect respectively. Using immunodeficient and monoclonal antibody-specific immunosuppression, we identified immune cell populations involved in the preventive (NK-cell dependent) and antitumor activity of H89 (T-cell dependent). Flow cytometry analysis showed that the antitumor effect of H89 was correlated with an increase in the tumor microenvironment of CD4+ Th1 cells and CD8+ cytotoxic T cells and a decrease of CD4+ Treg cells infiltration. Furthermore, qRT-PCR revealed that H89 can promote naïve CD4+ T cells differentiation into Th1, decreases Treg differentiation and increases ex vivo CD8+ T cell-mediated killing of cancer cells. An RNAseq profiling experiment showed that H89 induces an overexpression of genes involved in antitumor immune response, such as IL-15RA, whose inhibition counteracts the antitumor effect of H89. In conclusion, our findings identify H89 as a potential strategy for the prevention and treatment of CRC.
 
Overall design RNA profiles of CT26-tumor bearing Balb/c mice treated or not by the kinase inhibitor H89
 
Contributor(s) Ghione S, Racoeur C, Mabrouk N, Shan J, Groetz E, Ballot E, Truntzer C, Chouchane L, Vegran F, Paul C, Plenchette S, Bettaieb A
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Feb 28, 2022
Last update date Mar 03, 2022
Contact name François Ghiringhelli
E-mail(s) [email protected], [email protected]
Organization name UMR INSERM 1231
Street address 1 rue du Professeur Marion
City DIJON
ZIP/Postal code 21000
Country France
 
Platforms (1)
GPL23479 BGISEQ-500 (Mus musculus)
Samples (6)
GSM5923390 Tumor 1_NaCl
GSM5923391 Tumor 2_NaCl
GSM5923392 Tumor 3_NaCl
Relations
BioProject PRJNA811154

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE197598_TPM.csv.gz 422.0 Kb (ftp)(http) CSV
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap